Accuracy of individual variables in the monitoring of long-term change in pulmonary sarcoidosis as judged by serial high-resolution CT scan data

Chest

Volumn 145, Issue 1, 2014, Pages 101-107

  Zappala, Christopher J ^a,b,d   Desai, Sujal R ^e   Copley, Susan J ^f   Spagnolo, Paolo ^b   Cramer, Derek ^b   Sen, Dushendree ^b   Alam, Salma M ^b   Du Bois, Roland M ^b   Hansell, David M ^c   Wells, Athol U ^b  

^a ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^b ROYAL BROMPTON HOSPITAL   (United Kingdom)

^c Department of Imaging ^*  (United Kingdom)

^d UNIVERSITY OF MELBOURNE   (Australia)

^e KING S COLLEGE HOSPITAL   (United Kingdom)

^f HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CLINICAL ASSESSMENT; DIAGNOSTIC IMAGING; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HUMAN; INTERMETHOD COMPARISON; KAPPA STATISTICS; LUNG DIFFUSION; LUNG DIFFUSION CAPACITY; LUNG SARCOIDOSIS; MAJOR CLINICAL STUDY; MALE; PATIENT MONITORING; PRIORITY JOURNAL; RADIOLOGIST; SCORING SYSTEM; SPIROMETRY; THORAX RADIOGRAPHY;

ADULT; BREATH TESTS; CARBON MONOXIDE; DISEASE PROGRESSION; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; LUNG; MALE; MIDDLE AGED; RESPIRATORY FUNCTION TESTS; SARCOIDOSIS, PULMONARY; TOMOGRAPHY, X-RAY COMPUTED; VITAL CAPACITY; X-RAYS;

EID: 84892664283     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.12-2479     Document Type: Article

References (18)

1. Statement on sarcoidosis. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999. Am J Respir Crit Care Med. 1999; 160 (2): 736-755.
2. Zappala CJ, Desai SR, Copley SJ, et al. Optimal scoring of serial change on chest radiography in sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis. 2011; 28 (2): 130-138.
3. Bradley B, Branley HM, Egan JJ, et al. Interstitial Lung Disease Guidelines: the British Thoracic Society in collaboration with the Thoracic Society of Australia and New Zealand and the Irish Thoracic Society. Thorax. 2008; 63 (suppl 5): 1-58.
4. Baumann MH, Strange C, Sahn SA. Do chest radiographic findings reflect the clinical course of patients with sarcoidosis during corticosteroid withdrawal? AJR Am J Roentgenol. 1990; 154 (3): 481-485.
5. Muers MF, Middleton WG, Gibson GJ, et al. A simple radiographic scoring method for monitoring pulmonary sarcoidosis: relations between radiographic scores, dyspnoea grade and respiratory function in the British Thoracic Society Study of Long-Term Corticosteroid Treatment. Sarcoidosis Vasc Diffuse Lung Dis. 1997; 14 (1): 46-56.
6. Judson MA, Gilbert GE, Rodgers JK, Greer CF, Schabel SI. The utility of the chest radiograph in diagnosing exacerbations of pulmonary sarcoidosis. Respirology. 2008; 13(1): 97- 102.
7. Emirgil C, Sobol BJ, Williams MH Jr. Long-term study of pulmonary sarcoidosis. The effect of steroid therapy as evaluated by pulmonary function studies. J Chronic Dis. 1969; 22 (2): 69-86.
8. Standardized lung function testing. Official statement of the European Respiratory Society. Eur Respir J Suppl. 1993; 16: 1-100.
9. Scadding JG. Prognosis of intrathoracic sarcoidosis in England. A review of 136 cases after five years' observation. BMJ. 1961; 2 (5261): 1165-1172.
10. American Thoracic Society; European Respiratory Society. American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001. Am J Respir Crit Care Med. 2002; 165(2): 277- 304.
11. Baughman RP, Shipley R, Desai S, et al Sarcoidosis Investigators. Changes in chest roentgenogram of sarcoidosis patients during a clinical trial of infliximab therapy: comparison of different methods of evaluation. Chest. 2009; 136 (2): 526-535.
12. Judson MA, Baughman RP, Thompson BW, et al ACCESS Research Group. Two year prognosis of sarcoidosis: the ACCESS experience. Sarcoidosis Vasc Diffuse Lung Dis. 2003; 20 (3): 204-211.
13. Winterbauer RH, Hutchinson JF. Use of pulmonary function tests in the management of sarcoidosis. Chest. 1980; 78 (4): 640-647.
14. Latsi PI, du Bois RM, Nicholson AG, et al. Fibrotic idiopathic interstitial pneumonia: the prognostic value of longitudinal functional trends. Am J Respir Crit Care Med. 2003; 168 (5): 531-537.
15. Flaherty KR, Andrei AC, Murray S, et al. Idiopathic pulmonary fibrosis: prognostic value of changes in physiology and six-minute-walk test. Am J Respir Crit Care Med. 2006; 174(7): 803-809.
16. Collard HR, King TE Jr, Bartelson BB, Vourlekis JS, Schwarz MI, Brown KK. Changes in clinical and physiologic variables predict survival in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2003; 168 (5): 538-542.
17. Baughman RP, Engel PJ, Meyer CA, Barrett AB, Lower EE. Pulmonary hypertension in sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis. 2006; 23 (2): 108-116.
18. Bourbonnais JM, Samavati L. Clinical predictors of pulmonary hypertension in sarcoidosis. Eur Respir J. 2008; 32 (2): 296-302.